oxymorphone hydrochloride

FDA Drug Profile — Oxymorphone Hydrochloride

oxymorphone hydrochloride is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Oxymorphone Hydrochloride. Available dosage form: tablet.

Drug details

Generic Name
oxymorphone hydrochloride
Brand Names
Oxymorphone Hydrochloride
Application Number
ANDA090964
Sponsor
Hikma Pharmaceuticals USA Inc.
NDC Codes
4
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
OXYMORPHONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS & USAGE Oxymorphone hydrochloride tablets is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, overdose and death which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.1)], reserve opioid analgesics, including oxymorphone hydrochloride tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Oxymorphone hydrochloride tablets is an opioid agonist indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. (1) Limitations of Use (1) Because of the risks of addiction, abuse, and misuse, overdose and death which can occur at any dosage or duration, and persist over the course of therapy, reserve opioid analgesics, including oxymorphone hydrochloride tablets, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. (1 , 5.1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.